Jones Day Adds to Strong M&A lineup with Partners in Chicago and Detroit

Saturday, September 19, 2015 - 11:28

D. Michael Murray and Bryan Zair have joined Jones Day as partners in the firm's M&A Practice. Mr. Murray will be based in the Chicago Office, and Mr. Zair will join Jones Day's Detroit Office. Both lawyers were previously partners at Mayer Brown in Chicago.

"As companies continue to reconfigure their businesses and redeploy their balance sheets through strategic deals, there's great demand for lawyers like Mike and Bryan who have broad transactional experience and are comfortable counseling boards," said Bob Profusek, leader of Jones Day's global M&A Practice. 

Murray's transactional work has focused on stock and asset acquisitions and divestitures, mergers, joint ventures and strategic alliances. He also advises clients on corporate governance, SEC compliance, and defensive measures, including shareholders' rights plans. Some of Murray's most significant deals have included advising Prologis, Inc. in its $5.9 billion acquisition of the real estate assets and operating platform of KTR Capital Partners and its affiliates and its $5.5 billion acquisition of Catellus Development Corporation; Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, in the sale of its Viking and ProFume businesses to Altamont Capital Partners and Douglas Products and in an agreement under which Syngenta assumed responsibility for the supply and distribution of Dow AgroSciences crop protection products throughout the Commonwealth of Independent States (CIS) region; The Pritzker Group in its leveraged buy­out of Entertainment Cruises, Inc.; Mitsui & Co., Ltd. in its buy­out of two joint venture partners in Multigrain AG; and TransCanada Corporation in its $2.9 billion acquisition of the Ravenswood Power Generating Facility and its $3.4 billion acquisition of ANR Pipeline Company, ANR Storage Company, and an additional interest in Great Lakes Gas Transmission Limited Partnership. 

Zair represents publicly traded and privately held U.S., foreign, and multinational clients on a broad range of transactional and corporate matters, focusing primarily in the areas of M&A, joint ventures, strategic alliances and collaborations, as well as in other complex commercial arrangements. He also counsels clients on general corporate law matters, including corporate governance and compliance. His transactional experience includes advising The Dow Chemical Company and Dow AgroSciences in a variety of corporate transactional matters throughout the world, including the formation of America Styrenics LLC, a joint venture with Chevron Phillips Chemical Company LP; the sale of Dexco Polymers L.P., a joint venture of Dow and ExxonMobil Chemical Company to TSRC Corporation; and the sale of Dow AgroSciences' Vikane and ProFume businesses to Altamont Capital Partners and Douglas Products. Zair also represented Baxter Healthcare Corporation in connection with the sale of its U.S. generic injectables business, and the founders of CDMI, LLC, a privately held drug benefit management company, in connection with their sale of 100 percent of the equity interests in CDMI to Magellan Health Services, Inc., for a purchase price (including potential contingent payments) of $375 million.